Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹200 | - |
Expense Ratio | 2.45 | - |
NAV | ₹28.73 | - |
Fund Started | 08 Feb 2019 | - |
Fund Size | ₹83.12 Cr | - |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | - |
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹200
-
Expense Ratio
2.45
-
NAV
₹28.73
-
Fund Started
08 Feb 2019
-
Fund Size
₹83.12 Cr
-
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
-
1 Year | -0.74% | - |
3 Year | 19.68% | - |
5 Year | 11.20% | - |
1 Year
-0.74%
-
3 Year
19.68%
-
5 Year
11.20%
-
Equity | 98.02% | - |
Cash | 1.98% | - |
Equity
98.02%
-
Cash
1.98%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.85% |
Torrent Pharmaceuticals Ltd. | 6.08% |
Apollo Hospitals Enterprise Ltd. | 5.70% |
Cipla Ltd. | 5.68% |
Divi's Laboratories Ltd. | 4.74% |
Neuland Laboratories Ltd. | 4.51% |
Fortis Healthcare Ltd. | 4.48% |
Aurobindo Pharma Ltd. | 4.46% |
Piramal Pharma Ltd. | 4.32% |
Onesource Specialty Pharma Ltd. | 3.88% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. | - |
Launch Date | 08 Feb 2019 | - |
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
-
Launch Date
08 Feb 2019
-